Patrick L. McCollam

1.0k total citations
43 papers, 830 citations indexed

About

Patrick L. McCollam is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Patrick L. McCollam has authored 43 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 10 papers in Economics and Econometrics. Recurrent topics in Patrick L. McCollam's work include Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Acute Myocardial Infarction Research (16 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Patrick L. McCollam is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Acute Myocardial Infarction Research (16 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Patrick L. McCollam collaborates with scholars based in United States, United Kingdom and Belgium. Patrick L. McCollam's co-authors include Zhenxiang Zhao, Garth J. S. Cooper, Robert L. Kent, Robert B. Parker, Matthew Taylor, David E. Newby, Paul Scuffham, M Nagatsu, Hiroyuki Tsutsui and Hirofumi Tagawa and has published in prestigious journals such as Circulation, American Journal of Epidemiology and The American Journal of Cardiology.

In The Last Decade

Patrick L. McCollam

42 papers receiving 801 citations

Peers

Countries citing papers authored by Patrick L. McCollam

Since Specialization

Citations

This map shows the geographic impact of Patrick L. McCollam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick L. McCollam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick L. McCollam more than expected).

Fields of papers citing papers by Patrick L. McCollam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick L. McCollam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick L. McCollam. The network helps show where Patrick L. McCollam may publish in the future.

Co-authorship network of co-authors of Patrick L. McCollam

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick L. McCollam. A scholar is included among the top collaborators of Patrick L. McCollam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick L. McCollam. Patrick L. McCollam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study 2021 ·Advances in Therapy ·(unknown), (unknown), (unknown), Mark Belger, (unknown), Patrick L. McCollam, Theodore E. Spiro, Russel Burge	11
2	One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database 2017 ·American Journal of Cardiovascular Drugs ·Mark B. Effron, Kavita Nair, (unknown), Stuart Keller, Robert L. Page, Jason C. Simeone, Brian R. Murphy, Beth Nordstrom, Yajun Emily Zhu, Patrick L. McCollam, George W. Vetrovec	7
3	Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial 2016 ·American Heart Journal ·Padma Kaul, E. Magnus Ohman, J. David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden, Judith S. Hochman, Vladimir Gašparović, Paul W. Armstrong, Patrick L. McCollam, (unknown), Patricia A. Cowper, Linda Davidson‐Ray, Nancy E. Clapp‐Channing, Harvey D. White, Keith A.A. Fox, Dorairaj Prabhakaran, Daniel B. Mark	3
4	One-Year Post-Discharge Resource Utilization and Treatment Patterns of Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention and Treated with Ticagrelor or Prasugrel 2015 ·American Journal of Cardiovascular Drugs ·Jason C. Simeone, (unknown), Elizabeth Marrett, Feride Frech‐Tamas, Mark B. Effron, Beth Nordstrom, Yajun Emily Zhu, Stuart Keller, Brian R. Murphy, Kavita Nair, George W. Vetrovec, Robert L. Page, Patrick L. McCollam	18
5	Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor 2015 ·Journal of Medical Economics ·(unknown), Feride Frech‐Tamas, Mitch DeKoven, Mark B. Effron, Swapna Karkare, Yajun Emily Zhu, (unknown), Jingsong Lu, Patrick L. McCollam, Elizabeth Marrett, George W. Vetrovec	6
6	Health Care Costs And Resource Utilization In Working Age Patients With High Risk Vascular Disease: Findings From A Multi-Employer Claims Database 2014 ·Value in Health ·(unknown), Y. Zhu, Yun Fang, Patrick L. McCollam	1
7	Adherence and Persistence with Prasugrel Following Acute Coronary Syndrome with Percutaneous Coronary Intervention 2013 ·American Journal of Cardiovascular Drugs ·Beth Nordstrom, Jason C. Simeone, Zhenxiang Zhao, (unknown), Patrick L. McCollam, Xin Ye, Mark B. Effron	20
8	Adherence and dosing frequency of common medications for cardiovascular patients. 2012 ·PubMed ·Jay Bae, Paul P. Dobesh, Donald G. Klepser, (unknown), Anthony J. Zagar, Patrick L. McCollam, Molly Tomlin	61
9	Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization. 2005 ·PubMed ·Patrick L. McCollam, (unknown)	15
10	Total First-Year Costs of Acute Coronary Syndrome in a Managed Care Setting 2005 ·Journal of Managed Care Pharmacy ·(unknown), Patrick L. McCollam	67
11	Predictors of high-cost managed care patients with acute coronary syndrome 2005 ·Current Medical Research and Opinion ·(unknown), Patrick L. McCollam	13
12	Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients 2001 ·Catheterization and Cardiovascular Interventions ·Maureen J. Lage, Beth Barber, Patrick L. McCollam, Mohan Bala, Joel Scherer	7
13	Impact of abciximab versus tirofiban on hospital length of stay for PCI patients 2001 ·Catheterization and Cardiovascular Interventions ·Maureen J. Lage, Beth Barber, Patrick L. McCollam, Mohan Bala, Joel Scherer	5
14	Caucasian versus African‐American Differences in Orosomucoid: Potential Implications for Therapy 1998 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Patrick L. McCollam, Michael A. Crouch, Philippe Arnaud	9
15	Altered Protein Binding of Quinidine in Patients with Atrial Fibrillation and Flutter 1997 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Patrick L. McCollam, Michael A. Crouch, (unknown)	7
16	Concomitant Amiodarone and the Implantable Cardioverter-Defibrillator: Is There a Place? 1993 ·Annals of Pharmacotherapy ·Patrick L. McCollam, Jean M. Nappi, (unknown), (unknown)	2
17	Sotalol: A Breakthrough Antiarrhythmic? 1993 ·Annals of Pharmacotherapy ·Jean M. Nappi, Patrick L. McCollam	8
18	Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects 1992 ·The American Journal of Cardiology ·(unknown), Patrick L. McCollam, Karen J. Beckman, Robert J. Hariman, Jerry L. Bauman	12
19	A simple method of monitoring antiarrhythmic drugs during short- and long-term therapy 1989 ·The American Journal of Cardiology ·Patrick L. McCollam, Jerry L. Bauman, Karen J. Beckman, Robert J. Hariman	5
20	Proarrhythmia: A Paradoxic Response to Antiarrhythmic Agents 1989 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Patrick L. McCollam, Robert B. Parker, Karen J. Beckman, Robert J. Hariman, Jerry L. Bauman	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact